DE2558719C3 - - Google Patents
Info
- Publication number
- DE2558719C3 DE2558719C3 DE19752558719 DE2558719A DE2558719C3 DE 2558719 C3 DE2558719 C3 DE 2558719C3 DE 19752558719 DE19752558719 DE 19752558719 DE 2558719 A DE2558719 A DE 2558719A DE 2558719 C3 DE2558719 C3 DE 2558719C3
- Authority
- DE
- Germany
- Prior art keywords
- ethyl
- phenoxy
- acid
- acceptable salts
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 6
- -1 2,4-dichlorobenzoylamino Chemical group 0.000 claims description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000004494 ethyl ester group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZPQOPVIELGIULI-UHFFFAOYSA-N 1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1 ZPQOPVIELGIULI-UHFFFAOYSA-N 0.000 description 1
- FUJSJWRORKKPAI-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetyl chloride Chemical compound ClC(=O)COC1=CC=C(Cl)C=C1Cl FUJSJWRORKKPAI-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- XWGHVMINUAWSOP-UHFFFAOYSA-N CC(C)(C(O)=O)OC1=CC=C(CCNC(C(C=CC(Cl)=C2)=C2Cl)=O)C=C1 Chemical compound CC(C)(C(O)=O)OC1=CC=C(CCNC(C(C=CC(Cl)=C2)=C2Cl)=O)C=C1 XWGHVMINUAWSOP-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 1
- 229950008441 clofibric acid Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752558719 DE2558719B2 (de) | 1975-12-24 | 1975-12-24 | Alpha-geschweifte klammer auf 4- eckige klammer auf 2-(2.4-dichlorbenzoylamino) -aethyl eckige klammer zu -phenoxy geschweifte klammer zu-isobuttersaeure, deren methyl- und aethylester sowie deren pharmakologisch vertraegliche salze und arzneimittel, die diese verbindungen enthalten |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752558719 DE2558719B2 (de) | 1975-12-24 | 1975-12-24 | Alpha-geschweifte klammer auf 4- eckige klammer auf 2-(2.4-dichlorbenzoylamino) -aethyl eckige klammer zu -phenoxy geschweifte klammer zu-isobuttersaeure, deren methyl- und aethylester sowie deren pharmakologisch vertraegliche salze und arzneimittel, die diese verbindungen enthalten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2558719A1 DE2558719A1 (de) | 1977-06-30 |
| DE2558719B2 DE2558719B2 (de) | 1977-12-01 |
| DE2558719C3 true DE2558719C3 (enrdf_load_stackoverflow) | 1978-08-24 |
Family
ID=5965657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752558719 Granted DE2558719B2 (de) | 1975-12-24 | 1975-12-24 | Alpha-geschweifte klammer auf 4- eckige klammer auf 2-(2.4-dichlorbenzoylamino) -aethyl eckige klammer zu -phenoxy geschweifte klammer zu-isobuttersaeure, deren methyl- und aethylester sowie deren pharmakologisch vertraegliche salze und arzneimittel, die diese verbindungen enthalten |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2558719B2 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2898892A1 (fr) * | 2006-03-24 | 2007-09-28 | Genfit Sa | Derives de n-(phenethyl)benzamide substitues,preparation et utilisations |
-
1975
- 1975-12-24 DE DE19752558719 patent/DE2558719B2/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2558719A1 (de) | 1977-06-30 |
| DE2558719B2 (de) | 1977-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2230383C3 (de) | Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben | |
| DE2324768C2 (de) | 2-Amino-3-(oder 5-)benzoylphenylessigsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende Mittel | |
| DE1914999A1 (de) | Neue Guanylhydrazone und Verfahren zu ihrer Herstellung | |
| DE2532420A1 (de) | Phenylessigsaeure-derivate und verfahren zu ihrer herstellung | |
| CH628614A5 (de) | Verfahren zur herstellung von substituierten n-aralkyl- und n-aralkenyl-amino-benzoesaeurederivaten. | |
| DE1593027A1 (de) | Alkensaeuren und Verfahren zu ihrer Herstellung | |
| DE3326164A1 (de) | Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE2449205C2 (de) | Substituierte Furylverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CH622491A5 (en) | Process for the preparation of novel hydroxypropylamines | |
| DE2558719C3 (enrdf_load_stackoverflow) | ||
| DE2521347C3 (de) | Hydroxylsubstituierte 2-Chlor- a, -(tertbutylaminomethyl)-benzylalkohole, Herstellungsverfahren und Arzneimittel | |
| DD150060A5 (de) | Verfahren zur herstellung von neuen phenthiazin-derivaten | |
| DE1817740C3 (enrdf_load_stackoverflow) | ||
| DE2559596C3 (de) | Phenoxyheptansäurederivate und Arzneimittel, die diese Verbindungen enthalten | |
| DE2024049B2 (de) | Alpha-(3,4-dihydroxyphenyl)-alpha(2-piperidinyl)-methanol | |
| DE2201804C3 (de) | Phenyläthylbenzylamine und Verfahren zu ihrer Herstellung | |
| DE1668199B2 (de) | Benzolsulfonyl-3-(2-hydroxycyclohexyl)harnstoffe | |
| DE1493856C3 (enrdf_load_stackoverflow) | ||
| DE1668199C3 (de) | Benzolsulfonyl-3-(2-hydroxycyclohexyl)harnstoffe | |
| DE1543744C3 (de) | 3-Alkylflavanone und Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
| DE1122070C2 (de) | Verfahren zur Herstellung von diuretisch wirksamen Disulfamylanilinverbindungen | |
| DE1200832B (de) | Verfahren zur Herstellung von 3, 5-Dijodthyroninderivaten | |
| DE1568959C (de) | 2,4,6-Trijod-3-hydroxy-benzamide und deren nichttoxische Salze bzw. Phenolate sowie Verfahren zu deren Herstellung | |
| DE1100619B (de) | Verfahren zur Herstellung von 3-Aralkyl-2-aminoalkylindenen mit Antihistaminwirkung | |
| DE1955386C3 (de) | 2-(5'-Nitro-2'-furfuryliden)-indanone und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) |